Sinopharm Group Co Ltd
F:X2S
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
S
|
Sinopharm Group Co Ltd
F:X2S
|
CN |
|
Globalstar Inc
F:P8S
|
US |
|
K
|
Kangda International Environmental Company Ltd
SWB:27K
|
CN |
|
N
|
National Retail Properties Inc
F:CZ2
|
US |
|
Celularity Inc
NASDAQ:CELU
|
US |
|
Abeona Therapeutics Inc
NASDAQ:ABEO
|
US |
|
Nippon Steel Corp
TSE:5401
|
JP |
|
E
|
Evonik Industries AG
OTC:EVKIF
|
DE |
|
L
|
LTMH PCL
SET:LTMH
|
TH |
|
N
|
Nippon Steel Corp
OTC:NPSCY
|
JP |
|
V
|
Viet Nam Rubber Group JSC
VN:GVR
|
VN |
|
DMG Mori Co Ltd
F:0MO
|
JP |
|
Showcase Inc
TSE:3909
|
JP |
Wall St Price Targets
X2S Price Targets Summary
Sinopharm Group Co Ltd
According to Wall Street analysts, the average 1-year price target for X2S is 3.057 EUR with a low forecast of 2.276 EUR and a high forecast of 3.754 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is X2S's stock price target?
Price Target
3.057
EUR
According to Wall Street analysts, the average 1-year price target for X2S is 3.057 EUR with a low forecast of 2.276 EUR and a high forecast of 3.754 EUR.
What is the Revenue forecast for Sinopharm Group Co Ltd?
Projected CAGR
5%
Over the last 14 years, the compound annual growth rate for Revenue has been 13%. The projected CAGR for the next 3 years is 5%.
What is the Gross Profit forecast for Sinopharm Group Co Ltd?
Projected CAGR
9%
Over the last 14 years, the compound annual growth rate for Gross Profit has been 12%. The projected CAGR for the next 3 years is 9%.
What is the Operating Income forecast for Sinopharm Group Co Ltd?
Projected CAGR
9%
Over the last 14 years, the compound annual growth rate for Operating Income has been 11%. The projected CAGR for the next 3 years is 9%.
What is the Pre-Tax Income forecast for Sinopharm Group Co Ltd?
Projected CAGR
10%
Over the last 14 years, the compound annual growth rate for Pre-Tax Income has been 12%. The projected CAGR for the next 3 years is 10%.
What is the Net Income forecast for Sinopharm Group Co Ltd?
Projected CAGR
10%
Over the last 14 years, the compound annual growth rate for Net Income has been 11%. The projected CAGR for the next 3 years is 10%.
